Asaf Alperovitz
CIK 1449373 · Chief Financial Officer · last filed 2026-01-05
Asaf Alperovitz is a Chief Financial Officer who has filed 3 SEC Form 4 insider transactions across 2 companies since 2008. The most recent filing, for SEDG, was dated Jan 5, 2026. Current disclosed insider exposure totals $3.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.63M
2
3
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SEDG | Chief Financial Officer | 59,681 | $60.80 | $3.63M | $0 | 2 | 2026-01-05 |
| Omrix Biopharmaceuticals, Inc. (OMRI) Delisted | Chief Financial Officer | — | — | — | $0 | 1 | 2008-11-05 |
Recent Filings
3 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-05 | SEDG | Grant (A) | +22,321 | $0 | EDGAR |
| 2025-03-25 | SEDG | Grant (A) | +37,360 | $0 | EDGAR |
| 2008-11-05 | Omrix Biopharmaceuticals, Inc. (OMRI) Delisted | Grant (A) | — | $0 | EDGAR |